Oncogene · 2002 · 32 citations · 23 references
PharmacyImmunologyOncologyDrug DiscoveryInflammationProdrug DesignAnticancer Prodrug DesignCancer ImmunotherapyInflammatory SignalingTargeted Cancer TherapyTargeted Prodrug DeliveryTumor-activated ProdrugsSite-selective ActivationSite-specific ActivationSite-specific Prodrug ActivationTumor Necrosis Factor Receptor 1 SignalingTumor Necrosis Factor TherapyTumor Tissue TargetingTumor-targeted Peptide ProdrugsTumor-targeted Prodrugs
23
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Roy A. Black, Charles T. Rauch, Carl J. Kozlosky et al. · Nature · 1997 · 3.1K citations